Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03008018
Title Safety,Tolerability and MTD KA2507 (HDAC6 Inhibitor) in Patients With Solid Tumours
Acronym HDAC6i
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Karus Therapeutics Limited
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.